Navigation Links
Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes

AUSTIN, Texas, Nov. 9 /PRNewswire/ -- Celling Technologies, a subsidiary of SpineSmith Partners, is collaborating with Tissue Genesis, Inc. to research potential applications for adipose tissue derived adult stem cells. SpineSmith acquired the global rights in spine for Tissue Genesis' adipose (fat) tissue derived stem cell technology in November of 2007. Replacing the prior arrangement, this new exclusive agreement allows Celling Technologies to further research adipose tissue derived stem cells in a variety of human applications, including orthopedics, vascular, trauma, plastics and disease, in certain agreed upon medical institutes.

Celling's team of scientists will collaborate with Tissue Genesis, and its licensees, to research adipose tissue derived stem cell applications at certain medical institutions throughout the world. "We believe adult stem cells will revolutionize modern medicine, and our business development efforts are positioning the company to continue leading the research and development of cellular therapy. The agreement with Tissue Genesis solidifies our position as a leader, and continues to build the opportunity for surgeons and institutions interested in the future of regenerative medicine," says Kevin Were, Director of Business Development for Celling Technologies.

This agreement allows Celling Technologies to offer Tissue Genesis' technology into its expanding network of surgeons and facilities around the world. The Regenerative Institute platform allows for collaboration between scientists, engineers and surgeons to drive research validating the efficacy of these adult stem cell therapies. "We believe our agreement with Celling Technologies gives Tissue Genesis a unique relationship to expand research with our Cell Isolation System technology, and collaborating with scientists and physicians," says Anton Krucky, CEO of Tissue Genesis.

The Tissue Genesis Cell Isolation System rapidly processes (in about an hour) autologous (patient-derived) adipose tissue and concentrates large quantities of regenerative cells (including adult stem cells) at point of care. This technology matches well with the current SpineSmith product portfolio of surgical implants and the current cell therapy products being investigated by Celling Technologies.

About SpineSmith Partners, LP

SpineSmith Partners, LP is dedicated to creating better ways to facilitate and accelerate the healing of spinal disorders through integration of innovative medical devices and biologic technologies. SpineSmith designs, develops, and markets implants and biologics for surgical fixation, correction, and tissue regeneration of the spine. SpineSmith's dedication to a collaborative approach between scientists, engineers and spine surgeons results in the development of truly innovative biological and hardware technologies.

About Celling Technologies

Celling Technologies, a SpineSmith Partners company, works closely with surgeons, scientists and engineers to research and develop innovative technologies in the emerging field of regenerative medicine. Celling's product offering focuses on autologous adult stem cell therapy and the devices and services that complement these procedures

About Tissue Genesis, Inc.

An emerging leader in adipose-derived cell therapy and regenerative medicine, Tissue Genesis, Inc. is a high-growth, clinical-stage company based in Honolulu, Hawai'i. Industry-leading engineers and scientists have developed a proprietary process for Tissue Genesis that may deliver innovative medical solutions for a wide range of existing medical problems, including: cardiac and peripheral vascular disease; orthopedic injuries; cosmetic and soft tissue defects; and many other applications. For more information, visit

SOURCE Celling Technologies

SOURCE Celling Technologies
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance
2. Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
3. TOPAZ Technologies and Tecniplast USA Launch RFID Mobile Census
4. Competitive Technologies Selects RF
5. Binder as Public Relations Agency of Record
6. Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings
7. Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy
8. Leading Event for People With Disabilities on November 6-8 Features Latest Technologies, Products, Services, and More
9. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
10. China Medical Technologies to Hold its Annual General Meeting on November 16, 2009
11. Palatin Technologies to Present at 8th Annual BIO Investor Forum
Post Your Comments:
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  Today, ... the launch of CareFront, a first-of-its-kind population health ... diagnosed with cancer. Designed to be built into ... cancer patients with resources for their care and ... program also offers tools to help patients understand ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from 2011 ... according to a recent study by the Workers Compensation Research Institute (WCRI). , ... per claim with more than seven days of lost time continued to be higher ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... technicians must mark the film for accurate interpretation by the radiologist. The marking ... an inventor from Sacramento, Calif., has found a way to alleviate this problem. ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):